Jane Street
MEDS

Jane Street’s DataMeds AI MEDS Stock Holding History

Jane Street’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.6K Buy
20,532
+18,652
+992% +$91.7K ﹤0.01% 10831
2026
Q1 		$9.06K Buy
1,880
+1,044
+125% +$14.3K ﹤0.01% 11315
2025
Q4 		$16.7K Buy
+836
New +$24.5K ﹤0.01% 10763

Other funds holding MEDS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Jane Street's MEDS Position: Q2 2026 in Review

Jane Street increased its DataMeds AI (MEDS) stake by 992% in Q2 2026, buying an estimated $91.7K and bringing the position to 20,532 shares worth $63.6K. The position accounts for ﹤0.01% of the portfolio, ranked #10831.

Jane Street first reported a position in MEDS in Q4 2025 and has held it in 3 quarters since. 9 funds tracked by Wall St. Rank hold MEDS as of Q2 2026.

  • Jane Street held 20,532 shares of DataMeds AI worth $63.6K as of Q2 2026.
  • Jane Street bought 18,652 DataMeds AI shares in Q2 2026, an estimated $91.7K.
  • DataMeds AI made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10831 holding.
  • Jane Street first reported a position in DataMeds AI in Q4 2025 and has held it in 3 quarters since.
  • 9 funds tracked by Wall St. Rank held DataMeds AI as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.